<DOC>
	<DOCNO>NCT00246597</DOCNO>
	<brief_summary>The purpose study determine whether possible measure temporary difficulty think and/or short-term memory woman receive chemotherapy early stage breast cancer determine whether treatment PROCRITÂ® help decrease problem think short-term memory chemotherapy may cause .</brief_summary>
	<brief_title>A Phase III Clinical Trial PROCRIT ( Epoetin Alfa ) Versus Placebo Women Undergoing Adjuvant Chemotherapy Stage I , II III Breast Cancer</brief_title>
	<detailed_description>Studies effect erythropoietin rat mouse brain suggest neuroprotective cognitive-enhancing effect hormone . The objective study quantify compare incidence chemotherapy-related impairment cognitive executive function breast cancer patient randomize receive PROCRIT versus placebo receive adjuvant anthracycline-based chemotherapy without Taxane evaluate effect PROCRIT® incidence asthenia ( severe fatigue ) , quality life ( QoL ) , mood . Patients receive study medication injection ( 40,000 unit ) skin every week 12 24 week chemotherapy . Doses adjust depend patient ' hemoglobin level maximum 60,000 unit .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Histologic diagnosis Stage I , II III cancer ( chemotherapy naïve breast cancer ) anthracyclinebased adjuvant chemotherapy without taxane Hemoglobin &gt; =9 &lt; =14 g/dL unrelated transfusion Able read , understand complete QoL &amp; Cognition tool Patients reproductive potential must negative serum pregnancy test within 7 day study enrollment use adequate contraceptive method Patients receive total 24 week chemotherapy psychiatric neurologic condition would prevent informed consent completion questionnaires poorly control current treatment regimen severe hemiparesis condition , distal neuropathy , action tremor motor dysfunction , visual deficiency preventing/decrease bimanual keyboard operation severe bradyphrenia ( slow thinking ) bradykinesia ( slow movement )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Anemia</keyword>
	<keyword>Breast cancer</keyword>
	<keyword>Hemoglobin</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Adjuvant Chemotherapy</keyword>
	<keyword>Pure red cell aplasia ( PRCA )</keyword>
	<keyword>Cognitive executive function</keyword>
</DOC>